Moraxella catarrhalis pneumonia during HIV disease

Journal of Chemotherapy

Volumn 12, Issue 5, 2000, Pages 406-411

  Manfredi, R ^a   Nanetti, A ^a   Valentini, R ^a   Chiodo, F ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

AIDS; Antimicrobial susceptibility; HIV disease; Moraxella catarrhalis; Pneumonia; Respiratory tract infection

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; ANTIRETROVIRUS AGENT; AZTREONAM; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; CLARITHROMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; GENTAMICIN; IMIPENEM; MEZLOCILLIN; NETILMICIN; PIPERACILLIN; TIMENTIN; TOBRAMYCIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM ISOLATION; CHILD; CLINICAL FEATURE; COMORBIDITY; DISEASE SEVERITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; LEUKOPENIA; LYMPHOCYTE COUNT; MALE; MORAXELLA CATARRHALIS; MYCOBACTERIUM TUBERCULOSIS; NEUTROPENIA; PNEUMONIA; RESPIRATORY TRACT INFECTION; STREPTOCOCCUS PNEUMONIAE; TREATMENT OUTCOME; VERTICAL TRANSMISSION;

EID: 0033762436     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2000.12.5.406     Document Type: Article

References (31)

1. Moraxella (Branhamella) catarrhalis
2. Interpretation of gram-stained sputa containing Moraxella (Branhamella) catarrhalis
3. Lung infections. Branhamella catarrhalis: Epidemiological and clinical aspects of a human respiratory tract pathogen
4. Infective exacerbations of chronic bronchitis: Relation between bacteriologic etiology and lung function
5. Moraxella catarrhalis: Clinical significance, antimicrobial susceptibility and BRO beta-lactamases
6. Moraxella (Branhamella) catarrhalis: Clinical, microbiological, and immunological features in lower respiratory tract infections
7. Spectrum and significance of bacteremia due to Moraxella catarrhalis
8. Moraxella (Branhamella) catarrhalis bacteremia in children. A report of two patients and review of the literature
9. Moraxella catarrhalis bacteraemia. A report on 3 cases and a review of the literature
10. Characterization of hospital isolates of Moraxella (Branhamella) catarrhalis by SDS-PAGE of whole-cell proteins, immunoblotting and restriction-endonuclease analysis
11. Survey of susceptibilities of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis isolates to 26 antimicrobial agents: A prospective U.S. study
12. Bacterial pneumonia in patients with the acquired immunodeficiency syndrome
13. Bacterial infections in adult patients with the acquired immune deficiency syndrome (AIDS) and AIDS-related complex
14. Empirical treatment without bronchoscopy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome
15. Pyogenic bacterial pneumonia in human immunodeficiency virus-infected inpatients: A clinical, radiological, microbiological, and epidemiological study
16. Microbiology of community-acquired bacterial pneumonia in persons with and at risk for human immunodeficiency virus type 1 infection
17. Bacterial pneumonia in persons infected with the human immumodeficiency virus
18. Branhamella catarrhalis septicemia in an infant with AIDS
19. Management of the HIV-infected patient. Bacterial infections
20. Bacterial infections in HIV: The extent and nature of the problem
21. Editorial response: Changing epidemiology of nosocomial infections in human immunodeficiency virus-infected patients
22. Bacterial pneumonia in HIV-infected patients; analysis of risk factors and prognostic indicators
23. Pneumonia in the patient with HIV infection
24. HIV-associated non-mycobacterial sepsis-bacteraemia, before and during the highly active antiretroviral therapy era
25. Community-acquired bacteraemia in HIV-positive patients: Protective benefit of co-trimoxazole
26. Highly active antiretroviral therapy decreases the incidence of bacteremia in human immunodeficiency virus-infected individuals
27. Nosocomial infections in human immunodeficiency virus-infected patients in a long-term care setting
28. Bacterial bronchitis and bronchiectasis in human immunodeficiency virus infection
29. Pneumonia in patients with HIV infection
30. Sinusitis in human immunodeficiency virus infection: Typical and atypical organisms
31. Profile and trend of antimicrobial resistance of non-opportunistic bacterial pathogens isolated from patients with HIV infection